27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

ELDN Insider Trading (Eledon Pharmaceuticals)

Insider Ownership Percentage: 13.80%
Insider Buying (Last 12 Months): $33,800.00
Insider Selling (Last 12 Months): $0.00

Eledon Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Eledon Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Eledon Pharmaceuticals Share Price & Price History

Current Price: $2.45
Price Change: Price Increase of +0.01 (0.41%)
As of 07/1/2022 04:59 PM ET

This chart shows the closing price history over time for ELDN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

Eledon Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/20/2021David-Alexandre C. GrosCEOBuy2,000$4.48$8,960.00View SEC Filing Icon  
8/17/2021David-Alexandre C. GrosCEOBuy4,000$6.21$24,840.007,000View SEC Filing Icon  
6/9/2021David-Alexandre C. GrosCEOBuy3,000$8.01$24,030.003,000View SEC Filing Icon  
See Full Table
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for Eledon Pharmaceuticals (NASDAQ:ELDN)

71.41% of Eledon Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ELDN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Eledon Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/16/2022Woodline Partners LP673,138$2.65M0.0%-13.9%4.893%Search for SEC Filing on Google Icon
5/16/2022State Street Corp44,692$0.18M0.0%+10.5%0.325%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC18,473$73K0.0%+35.1%0.134%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.679,243$2.68M0.0%+1.4%4.936%Search for SEC Filing on Google Icon
5/9/2022CM Management LLC225,000$0.89M0.7%+95.7%1.636%Search for SEC Filing on Google Icon
4/25/2022Bailard Inc.27,600$0.11M0.0%N/A0.193%Search for SEC Filing on Google Icon
2/14/2022Point72 Asset Management L.P.431,435$1.90M0.0%+105.9%3.016%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc77,100$0.34M0.0%+966.7%0.539%Search for SEC Filing on Google Icon
2/7/2022Ameritas Advisory Services LLC24,219$0.11M0.0%N/A0.169%Search for SEC Filing on Google Icon
2/2/2022CM Management LLC115,000$0.51M0.4%+53.3%0.804%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP115,900$0.72M0.0%+48.0%0.810%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP115,324$0.71M0.0%+100.5%0.806%Search for SEC Filing on Google Icon
11/16/2021BVF Inc. IL1,363,435$8.43M0.3%+22.5%9.530%Search for SEC Filing on Google Icon
11/15/2021Point72 Asset Management L.P.209,490$1.30M0.0%+11.0%1.464%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP114,008$0.71M0.1%N/A0.797%Search for SEC Filing on Google Icon
11/15/2021Ensign Peak Advisors Inc7,228$45K0.0%-80.0%0.051%Search for SEC Filing on Google Icon
11/10/2021Mercer Global Advisors Inc. ADV16,726$0.10M0.0%N/A0.117%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC350,000$2.77M0.2%+40.0%2.446%Search for SEC Filing on Google Icon
8/17/2021Woodline Partners LP857,445$6.78M0.1%-3.8%5.993%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC40,052$0.32M0.0%+39.6%0.280%Search for SEC Filing on Google Icon
8/16/2021Point72 Asset Management L.P.188,690$1.49M0.0%+51.0%1.319%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley851,004$6.73M0.0%+7,235.6%5.948%Search for SEC Filing on Google Icon
8/16/2021State Street Corp32,935$0.26M0.0%N/A0.230%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC21,107$0.17M0.0%-22.0%0.148%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp32,116$0.25M0.0%+106.8%0.224%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC124,614$0.99M0.0%+25.7%0.871%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.209,750$1.66M0.0%-8.8%1.466%Search for SEC Filing on Google Icon
5/19/2021Logos Global Management LP224,071$2.40M0.2%N/A1.566%Search for SEC Filing on Google Icon
5/18/2021BVF Inc. IL1,113,435$11.91M0.4%N/A7.782%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC14,588$0.16M0.0%N/A0.102%Search for SEC Filing on Google Icon
5/18/2021Point72 Asset Management L.P.125,000$1.34M0.0%N/A0.874%Search for SEC Filing on Google Icon
5/18/2021Cormorant Asset Management LP1,415,500$15.15M0.3%N/A9.894%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC25,062$0.27M0.0%N/A0.175%Search for SEC Filing on Google Icon
5/17/2021Woodline Partners LP891,055$9.53M0.2%N/A6.228%Search for SEC Filing on Google Icon
5/17/2021EcoR1 Capital LLC1,115,721$11.94M0.5%N/A7.798%Search for SEC Filing on Google Icon
5/17/2021Janus Henderson Group PLC213,899$2.25M0.0%N/A1.495%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC250,000$2.68M0.1%N/A1.747%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC27,051$0.29M0.0%N/A0.189%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp15,528$0.17M0.0%N/A0.109%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC99,123$1.06M0.0%N/A0.693%Search for SEC Filing on Google Icon
5/12/2021CM Management LLC75,000$0.80M0.6%N/A0.524%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.12,282$0.13M0.0%N/A0.086%Search for SEC Filing on Google Icon
4/21/2021Ingalls & Snyder LLC51,149$0.55M0.0%N/A0.358%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Eledon Pharmaceuticals logo
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Read More on Eledon Pharmaceuticals

Today's Range

Now: $2.45
Low: $2.35
High: $2.50

50 Day Range

MA: $2.95
Low: $2.34
High: $3.80

52 Week Range

Now: $2.45
Low: $2.27
High: $8.49

Volume

1,620 shs

Average Volume

68,824 shs

Market Capitalization

$33.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.98

Who are the company insiders with the largest holdings of Eledon Pharmaceuticals?

Eledon Pharmaceuticals' top insider shareholders include:
  1. David-Alexandre C Gros (CEO)
  2. David-Alexandre C Gros (CEO)
  3. Paul Sean Little (CFO)
Learn More about top insider investors at Eledon Pharmaceuticals.
Better Options For Trading!
I know–you’ve heard options trading is tough, but is it really tougher than the market is right now?

NO! “Options Trading Made Easy” by pro-trader Chuck Hughes gives traders the best options in an unpredictable market…

Get your copy now!
>>>